DK0396022T3 - Fremgangsmåde til isolering af blodkoagulationsfaktor IX - Google Patents

Fremgangsmåde til isolering af blodkoagulationsfaktor IX

Info

Publication number
DK0396022T3
DK0396022T3 DK90107974.9T DK90107974T DK0396022T3 DK 0396022 T3 DK0396022 T3 DK 0396022T3 DK 90107974 T DK90107974 T DK 90107974T DK 0396022 T3 DK0396022 T3 DK 0396022T3
Authority
DK
Denmark
Prior art keywords
blood coagulation
adsorption
coagulation factor
elution
onto
Prior art date
Application number
DK90107974.9T
Other languages
English (en)
Inventor
Wolfgang Dr Dipl-Chem Moeller
Michael Dipl-Biol Kraus
Bertram Dr Eichentopf
Original Assignee
Biotest Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma Gmbh filed Critical Biotest Pharma Gmbh
Application granted granted Critical
Publication of DK0396022T3 publication Critical patent/DK0396022T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90107974.9T 1989-05-05 1990-04-26 Fremgangsmåde til isolering af blodkoagulationsfaktor IX DK0396022T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914869A DE3914869C1 (da) 1989-05-05 1989-05-05

Publications (1)

Publication Number Publication Date
DK0396022T3 true DK0396022T3 (da) 1992-07-20

Family

ID=6380171

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90107974.9T DK0396022T3 (da) 1989-05-05 1990-04-26 Fremgangsmåde til isolering af blodkoagulationsfaktor IX

Country Status (8)

Country Link
US (1) US5061789A (da)
EP (1) EP0396022B1 (da)
JP (1) JP2593951B2 (da)
AT (1) ATE76751T1 (da)
DE (2) DE3914869C1 (da)
DK (1) DK0396022T3 (da)
ES (1) ES2037499T3 (da)
GR (1) GR3005036T3 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
AU671586B2 (en) 1991-03-01 1996-09-05 Aventis Behring Llc Preparation of factor IX
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE19504852C2 (de) * 1995-02-15 2003-01-23 Octapharma Ag Lachen Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DE10045434B4 (de) * 2000-09-14 2005-07-14 Fresenius Hemocare Gmbh Adsorbens mit unterschiedlich modifizierten Oberflächenbereichen, Verfahren zu dessen Herstellung und Verwendung davon
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7495426B2 (ja) 2019-03-14 2024-06-04 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥容器用充填治具、システム及び使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4447416A (en) * 1982-04-28 1984-05-08 American National Red Cross Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
DE3826792C1 (da) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
JP2593951B2 (ja) 1997-03-26
JPH02306994A (ja) 1990-12-20
ES2037499T3 (es) 1993-06-16
EP0396022B1 (de) 1992-06-03
EP0396022A1 (de) 1990-11-07
DE3914869C1 (da) 1990-08-09
DE59000141D1 (de) 1992-07-09
GR3005036T3 (da) 1993-05-24
US5061789A (en) 1991-10-29
ATE76751T1 (de) 1992-06-15

Similar Documents

Publication Publication Date Title
DK0396022T3 (da) Fremgangsmåde til isolering af blodkoagulationsfaktor IX
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
ES2051970T3 (es) Procedimiento para la preparacion de un concentrado de trombina muy puro.
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
Dubbelman et al. Photodynamic effects of hematoporphyrin-derivative on transmembrane transport systems of murine L929 fibroblasts
DE3382723D1 (de) Adsorbens und Verfahren zu dessen Herstellung.
ATE80803T1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
ES2121915T3 (es) Ligandos del receptor eck.
NO175562C (no) Fremgangsmåte for fjerning av kolesterol eller/og kolesterolestere fra eggeplomme
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
DK461781A (da) Derivatiseret agarose og fremgangsmaade til adskillelse af biolofiske stofblandinger ved gelelectrophorese under anvendelse af denne som gelmatrix
NO951761L (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
DK692987D0 (da) Middel og fremgangsmaade til adsorption af farlige, organiske spildvaesker og forhoejelse af deres flammepunkt
GB1527268A (en) Antiserum for the quantitative determination of the decomposition products x and y of fibrin and fibrinogen
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
DE58907555D1 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X.
SE8801426D0 (sv) Forfarande och medel for blodbehandling
ES530488A0 (es) Procedimiento para la fabricacion de derivados de plasma
BR9608147A (pt) Método para descontaminação microbiana de plaquetas sanguìneas.
EP0331327A3 (en) Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption
MY113294A (en) A process for the preparation of a virus inactivated fraction containing factor viii by means of chromatographic methods
Bartosz et al. Irradiation increases proteolysis in erythrocyte ghosts: a spin label study
ES2072331T3 (es) Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas.
ES2033830T3 (es) Procedimiento para producir compuestos macrolidos.
Dubbelman et al. Photodynamic inactivation of L929 cells after treatment with hematoporphyrin derivative